Daniel Mark Corey

Title: **The Innovations of Daniel Mark Corey: Pioneering Cancer Immunotherapy**

Introduction

Daniel Mark Corey, an inventive mind based in Palo Alto, California, has made significant strides in the field of cancer immunotherapy. With one patent to his name, he focuses on enhancing immune responsiveness toward target cancer cell populations, specifically utilizing apoptotic cells. His groundbreaking work offers new avenues for improving the body’s immune response to cancer and advancing treatment methods.

Latest Patents

Corey's patent, titled "Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells," addresses a critical issue in cancer treatment. The patent discusses the phenomenon of cell loss by apoptosis, which impedes the immune system's ability to combat tumorous cells. The innovative approach Corey devised involves using a fusion protein that combines a phosphatidylserine (PS) binding domain with an immunostimulatory domain, which aids in counteracting the immunosuppressive effects of apoptotic cell clearance. This innovative method not only enhances anti-tumor immunity but also boosts responses to immune checkpoint inhibitors and improves the effectiveness of engineered T cell transfers.

Career Highlights

Daniel Mark Corey has established himself as a respected inventor in the realm of cancer research while working at Leland Stanford Junior University. His contributions to the scientific community are evident through his focused research on harnessing the immune system's potential to fight cancer. By targeting apoptotic cells and leveraging their properties for immunotherapy, Corey is at the forefront of innovative treatments that may revolutionize cancer care.

Collaborations

Throughout his career, Corey has had the privilege of collaborating with esteemed colleagues such as Aaron Michael Ring and Melissa N McCracken. These partnerships have allowed for the exchange of ideas and insights, further enriching the research and development processes associated with his inventions. Together, they continue to push the boundaries of what is possible in cancer immunotherapy.

Conclusion

In conclusion, Daniel Mark Corey stands out as an innovative inventor whose work significantly contributes to the advancement of cancer treatment. His patent on enhancing immune responsiveness through apoptotic cells presents a promising direction for future therapies. With ongoing collaboration and research, Corey and his team may very well usher in a new era in the fight against cancer, demonstrating the profound impact of innovative thinking in medicine.